Beactica AB, the Swedish drug discovery company, announced that it has been awarded a grant of 2.8 MSEK from SweLife and Medtech4Health for its project focused on finding effective therapies for glioblastoma, an aggressive form of brain cancer.
June 18, 2019
· 1 min read